LawrenceMartinWeissMD
Pathology • Aliso Viejo, CAAnatomic Pathology, Clinical Pathology
Medical Director, Clarient, Inc.
Dr. Weiss is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
31 Columbia
Aliso Viejo, CA 92656Phone+1 949-643-7357Fax+1 949-425-5865
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Pathology-Anatomic and Clinical, 1983 - 1985
Brigham and Womens HospitalInternship, Transitional Year, 1982 - 1983- Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 1981 - 1981
University of Maryland School of MedicineClass of 1981
Certifications & Licensure
MA State Medical License 2023 - 2026
CA State Medical License 1984 - 2025
FL State Medical License 2012 - 2025
NY State Medical License 2012 - 2025
TX State Medical License 2014 - 2025
NC State Medical License 2017 - 2019- American Board of Pathology Anatomic Pathology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- Top Doctors:LA Area Castle Connolly, 2013
- Top Doctors:San Diego Area Castle Connolly, 2013
- Join now to see all
Publications & Presentations
PubMed
- 22 citationsNTRK fusions and Trk proteins: what are they and how to test for them.Lawrence M. Weiss, Vincent Funari
Human Pathology. 2021-03-29 - 5 citationsEBV-Associated Lymphoproliferative Disorders: Update in Classification.Sherif Rezk, Lawrence M. Weiss
Surgical Pathology Clinics. 2019-09-01 - 2 citationsEpstein-Barr virus incidental expression in bone marrow cells: a study of 230 consecutive bone marrow biopsy samplesDaniel Farrell, Ali Nael, Timothy Law, Xiaohui Zhao, Lawrence M. Weiss
Human Pathology. 2019-06-01
Press Mentions
EBV-Positive Plasmablastic Lymphoma Mimicking Reactive Lymphadenopathy Versus Recurrent Hodgkin Lymphoma Following Chemotherapy for Stage II Classical Hodgkin Lymphoma Cyrus Parsa1*, Robert Orlando2, Ravin Rupani3, Jin Guo4 and Dylan Denault5March 23rd, 2018
Grant Support
- Tissue Bank For Cellular And Molecular StudiesNational Cancer Institute2004–2008
- In Situ Hybridization In Hodgkins DiseaseNational Cancer Institute1994–1995
- In Situ Hybridization In Hodgkin'S DiseaseNational Cancer Institute1991–1993
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
